PP_1170x120_10-25-21

PSE

CHPA hails Georgia for adoption of PSE stop-sale system

CHPA hails Georgia for adoption of PSE stop-sale system

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has applauded Georgia for becoming the 33rd state to adopt real-time, stop-sale technology for illegal purchases of medication containing pseudoephedrine (PSE). Georgia Gov. Nathan Deal last week signed legislation, approved by the state legislature and sponsored by State Rep. David Clark Clark and State Sen. Renee Unterman (R.),

Consumers: Don’t impede access to PSE medicines

Consumers: Don’t impede access to PSE medicines

WASHINGTON — A survey by the Asthma and Allergy Foundation of America (AAFA) has revealed consumer concerns about access to over-the-counter cold/cough and allergy medicines containing pseudoephedrine (PSE). AAFA said Tuesday that the five-state survey of 2,027 users of OTC medicine for nasal allergies, asthma and/or cold, cough or flu, conducted by Harris Poll, shows

Adheris Health